Description
N/A
Screenshots
N/A FAQ
-
Is 河南润达医药 free?
Yes, 河南润达医药 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 河南润达医药 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 河南润达医药 cost?
河南润达医药 is free.
-
What is 河南润达医药 revenue?
To get estimated revenue of 河南润达医药 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Italy yet.
Ratings History
N/A Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
N/A Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
医捷通-医药招商.药品保健品代理平台
医捷通
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
天大馆医生端
人人可及的优质中医药服务
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
华杰全优采
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
泓坤医药网
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
一片天商城
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
海天药品
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
弘林医药
|
Unlock
|
Unlock
|
0
|
|
8 months ago | |
延耀在线
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
优药汇
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
立新药业
|
Unlock
|
Unlock
|
0
|
|
11 months ago |
河南润达医药 Installs
Last 30 days
河南润达医药 Revenue
Last 30 daysN/A Revenue and Downloads
Gain valuable insights into 河南润达医药 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 北京汉宁恒丰医药科技股份有限公司
- Languages
- Chinese
- Recent release
- 1.2 (1 year ago )
- Released on
- Mar 24, 2022 (2 years ago )
- Also available in
- Peru, India, Italy, Japan, Kuwait, Kazakhstan, Lebanon, Malaysia, Nigeria, Netherlands, New Zealand, Israel, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Türkiye, Ukraine, South Africa, Germany, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, Colombia, Czechia, Austria, Denmark, Algeria, Egypt, Spain, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland
- Last Updated
- 3 weeks ago